PDCD1 and skin squamous cell carcinoma: Kacew et al. analyzed 16 cSCC patients treated with a PD-1 inhibitor (not specified) and found that a higher frequency of CNAs was present in responders vs. non-responders (median: 97 vs. 47.5) [23].